Crescent Biopharma (CBIO) Assets Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Crescent Biopharma | 569.36 Mn | 380.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 42.43% |
| Dec 31, 2025 | 66.77% |
| Sep 30, 2025 | 35.19% |
| Jun 30, 2025 | 34.26% |
| Mar 31, 2025 | -58.10% |
| Dec 31, 2024 | -27.73% |
| Sep 30, 2024 | -47.41% |
| Jun 30, 2024 | -41.88% |
| Mar 31, 2024 | -37.19% |
| Dec 31, 2023 | -31.80% |
| Sep 30, 2023 | -29.28% |
| Jun 30, 2023 | -26.91% |
| Mar 31, 2023 | -24.80% |
| Dec 31, 2022 | -32.43% |
| Sep 30, 2022 | -32.31% |
| Jun 30, 2022 | -30.33% |
| Mar 31, 2022 | -26.41% |
| Dec 31, 2021 | -23.99% |
| Sep 30, 2021 | -21.74% |
| Jun 30, 2021 | -19.19% |
| Mar 31, 2021 | -17.68% |
| Dec 31, 2020 | 3.57% |
| Sep 30, 2020 | 9.10% |
| Jun 30, 2020 | 9.20% |
| Mar 31, 2020 | 63.37% |
| Dec 31, 2019 | 58.24% |
| Sep 30, 2019 | 55.48% |
| Jun 30, 2019 | 51.08% |
| Mar 31, 2019 | 71.26% |
| Dec 31, 2018 | 64.27% |
| Sep 30, 2018 | 59.26% |
| Jun 30, 2018 | 56.03% |
| Mar 31, 2018 | 72.19% |
| Dec 31, 2017 | 30.95% |
| Sep 30, 2017 | 22.87% |
| Jun 30, 2017 | 21.67% |
| Mar 31, 2017 | -13.81% |
| Dec 31, 2016 | 100.19% |